Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Hum Exp Toxicol ; 35(3): 232-43, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25882133

RESUMEN

The aim of the present study was to investigate the potential oxidative damage of di-(2-ethylhexyl) phthalate (DEHP) in the rat testis and to further elucidate the potential modulatory effect of quercetin. DEHP was diluted in corn oil and given to rats by oral gavage at doses 0, 300, 600, and 900 mg/kg/day (groups I, III, IV, or V, respectively) for 15 consecutive days. Group VI was pretreated with quercetin (90 mg/kg), 24 h before starting the experiment and then treated with DEHP (900 mg/kg/day) for 15 consecutive days. Group II was treated with quercetin (90 mg/kg/day). The relative testes weight and sperm motility were significantly decreased by treatment with 900 mg/kg of DEHP. Both sperm count and daily sperm production were significantly decreased by DEHP treatment at doses of 600 and 900 mg/kg. Serum testosterone level and prostatic acid phosphatase (ACP) activity and testicular lactate dehydrogenase-X (LDH-X) activity were significantly decreased in animals treated with 900 mg/kg. Serum total ACP activity was significantly increased in animals treated with 600 and 900 mg/kg of DEHP. DEHP treatment induced oxidative stress and histopathological abnormality. These abnormalities were effectively normalized by pretreatment with quercetin except for LDH-X near normalcy. In conclusion, the findings of this study demonstrate that DEHP impairs testicular function at least, in part, by inducing oxidative stress and quercetin has a potent protective effect against DEHP-induced testicular toxicity in rats.


Asunto(s)
Dietilhexil Ftalato/toxicidad , Plastificantes/toxicidad , Sustancias Protectoras/farmacología , Quercetina/farmacología , Testículo/efectos de los fármacos , Fosfatasa Ácida/metabolismo , Animales , Isoenzimas/metabolismo , L-Lactato Deshidrogenasa/metabolismo , Masculino , Próstata/efectos de los fármacos , Próstata/metabolismo , Ratas Wistar , Recuento de Espermatozoides , Motilidad Espermática/efectos de los fármacos , Testículo/metabolismo , Testículo/patología , Testosterona/sangre
2.
Toxicol Ind Health ; 25(6): 417-27, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19671635

RESUMEN

Benzo[alpha]pyrene (BaP) is one of the polycyclic aromatic hydrocarbons, which has shown carcinogenic, teratogenic, and mutagenic potentials. The reproductive toxicity of BaP in male was not well investigated. Thereby, we have addressed in the current study the testicular toxicity of BaP and the postulate whether or not the citrus flavonoid, hesperidin (HDN), could ameliorate such toxicity in male Swiss albino rats. In this sense, animals were challenged with BaP (50 mg/kg/day, orally) for 10 consecutive days. HDN (200 mg/kg/day, orally) was administered ahead of BaP challenge for 10 consecutive days. BaP induced testicular toxicity that was well characterized histologically and biochemically. It decreased the relative testis weight and induced pyknosis and necrobiotic changes as well as chromatolysis in the nuclei of the spermatocytes in the seminiferous tubules. It also markedly deteriorated epididymal function as shown by decreased sperm count, motility, and daily sperm production. The polyaromatic hydrocarbon also reduced the testicular activities of lactate dehydrogenase (LDH-X), superoxide dismutase (SOD), and glutathione-S-transferase (GST). Besides, it decreased the testicular reduced glutathione (GSH) but increased malondialdehyde (MDA) contents. Prior administration of HDN ahead of BaP challenge ameliorated all the histological and biochemical alterations induced by BaP. It improved the epididymal function and mitigated the injurious effects of BaP on the seminiferous tubules. In conclusion, HDN has proven protective effects in BaP-induced testicular toxicity paradigm, and this protection resides, at least in part, on its antioxidant properties.


Asunto(s)
Antioxidantes/farmacología , Hesperidina/farmacología , Enfermedades Testiculares/prevención & control , Testículo/efectos de los fármacos , Animales , Benzo(a)pireno/toxicidad , Carcinógenos/toxicidad , Modelos Animales de Enfermedad , Glutatión/metabolismo , Glutatión Transferasa/metabolismo , L-Lactato Deshidrogenasa/metabolismo , Masculino , Malondialdehído/metabolismo , Necrosis , Tamaño de los Órganos/efectos de los fármacos , Ratas , Túbulos Seminíferos/efectos de los fármacos , Túbulos Seminíferos/patología , Recuento de Espermatozoides , Espermatocitos/efectos de los fármacos , Espermatocitos/patología , Superóxido Dismutasa/metabolismo , Enfermedades Testiculares/inducido químicamente , Enfermedades Testiculares/metabolismo , Testículo/enzimología , Testículo/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA